What is Equillium Inc?
, a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 87.26M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 8406,392 shares $1.2M | 0 |
| 6-9months | 2301,531 shares $663k | 0 |
| 9-12months | 8336,272 shares $542k | 0 |